retatrutide mechanism retatrutide clinical trials trial Clinical Trial – My Endo Consult retatrutide mechanism of action clinical

In trials, GLP-1 options like Zepbound demonstrated significant weight reductions without relying solely on appetite suppression

However, glucagon also plays a significant role in energy expenditure

Larger molecules face increasing resistance

In most but not all studies, a small increase in white blood cell count (approximately 200 cells/microL difference in WBC vs placebo

The realistic timeline Based on the current state of the clinical program, regulatory precedent, and publicly available information from Eli Lilly, here is the most realistic projection: Mid to late 2026: Remaining TRIUMPH, TRANSCEND, and SYNERGY Phase 3 results are reported

Researchers planning longer-term protocols might benefit from purchasing supplies before this anticipated price pressure builds